Royalty Pharma plc
Largest buyer of biopharma royalties, providing non-dilutive funding for life sciences.
RPRX | US
Overview
Corporate Details
- ISIN(s):
- GB00BMVP7Y09
- LEI:
- Country:
- United States of America
- Address:
- 110 EAST 59TH STREET, 10022 NEW YORK
- Website:
- https://www.royaltypharma.com/
- Sector:
- Financial and insurance activities
- Industry:
- Activities of trusts, funds and similar financial entities
Description
Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences industry. Founded in 1996, the company specializes in acquiring revenue-producing royalties on marketed and late-stage biopharmaceutical products. It provides tailored, non-dilutive funding solutions to academic institutions, research hospitals, and biopharma companies in exchange for future royalty streams. As a pioneer and the market leader, Royalty Pharma manages a diversified portfolio of royalties on many of the world's leading therapies, operating at the intersection of science, medicine, and investing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Royalty Pharma plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Royalty Pharma plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Royalty Pharma plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
